- Trxade Group’s wholly owned subsidiary, Bonum Health, allows patients to access medical advice from the comfort of their homes
- Telemedicine is getting its moment in the clinical spotlight as COVID-19 contagion fears are being addressed by limiting face-to-face human interaction
- Congress has recently approved an $8.3 billion package which includes provisions for Medicare providers to provide telehealth services to their patients
With large swathes of the population increasingly concerned about leaving their homes and medical practitioners swamped amidst the ongoing viral crisis, telemedicine is getting its moment in the clinical spotlight. Bonum Health (http://ibn.fm/yvrNY), the wholly owned subsidiary of Trxade Group Inc. (NASDAQ: MEDS), is a virtual telehealth provider which helps patients easily and affordably access board-certified physicians and receive medical prescriptions from the comfort of their homes.
Telemedicine has gained particular prominence in recent days given the ongoing Coronavirus pandemic, which is primarily being tackled by limiting human face-to-face interaction. Telemedicine boasts a number of virtues – namely, the ability to offer customers a simplified and affordable manner in which to access medical professionals via their laptop or smartphones. However, it also enables patients who may be feeling unwell to avoid hospitals and teeming patient waiting rooms where the risk of COVID-19 contagion is significantly heightened.
“What telehealth can do is help both the clinicians as well as the consumer have access to service without actually getting exposed to the virus,” Ann Mond Johnson, CEO of the American Telemedicine Association (ATA), stated in a recent interview with ABC News. “It mitigates the risk. So in that regard it’s incredibly valuable.”
On March 4, 2020, Congress approved an $8.3 billion package (http://ibn.fm/G8r6e) in emergency aid to combat the novel coronavirus, which included provisions for Medicare providers to administer telehealth services so that elderly patients, a particularly vulnerable demographic, could receive care at home. The aid package was summarily followed by a coalition of private health insurers, who after a meeting at the White House on March 10, 2020, stated that they would pay for ‘virtual visits’ for patients who may have coronavirus so as to improve access to care for their customers (http://ibn.fm/QK8pG).
In light of the news, Trxade Group is leveraging upon Bonum Health’s unique healthcare platform to assist their members in gaining medical assurance in a quick, easy and relatively inexpensive manner. “With the seasonal flu outbreaks and the current coronavirus surge, patients are quick to brush off common symptoms, include cough, fever and body aches, as signs of a common cold”, Trxade Group’s news release states. “Telemedicine removes the barrier of self-doubt and complacency in the current climate of world-wide viral infections”. In an effort to further increase accessibility to their services, Trxade Group announced the recent launch of a new membership service from Bonum Health on March 10, 2020. The new service would allow subscribers to obtain three premium medical teleconferencing visits and free prescription delivery per month (http://ibn.fm/SFeSY).
Trxade Group is building a growing platform of integrated drug procurement, delivery and healthcare services to facilitate price transparency and increased profit margins for independent pharmacies within its network as well as pharmaceutical product sellers.
For more information, visit the company’s website at www.TrxadeGroup.com
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
